Mike Zhang | CEO Liaoning Chengda Biotechnology Co.,Ltd. | China
Phar-East Day One @ 09:40
The Macro View: What will it take for Asia’s biotech industry to really flourish?
Everyone knows it is too generic to classify all Asian countries in a single category. With the exception of China and India, the remaining part of Asia is complicated, fragmented and diversified. With growing GDPs and middle class populations, the potential of Asia’s biotech industry is undeniable in the eye of global leaders. The main question is, how can government and related stakeholders assist the biotech industry to flourish to provide more affordable, personalised medicine for its populations? How do countries move away from a “me-too” to “me-first” mentality, especially when it comes to pharma R&D?
Joe Zhou / The Macro View: What will it take for Asia’s biotech industry to really flourish?
Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group
Dr. Zhou, Xinhua (Dr. Joe Zhou) is the CEO of Genor Biopharma, a VP and the R&D head of Walvax Bio Group. He has been selected as a national expert of the TOP 1000 TALENTS program in China since 2010. Dr. Zhou also is a visiting professor teaching Master Degree Program in International...
Antonio Lee / The Macro View: What will it take for Asia’s biotech industry to really flourish?
Antonio Lee, Chief Executive Officer & Managing Director, MEDIPOST America
Dr. Antonio (Tony) Lee is the Global Head of Business Development at MEDIPOST (KOSDAQ: 078160; Seoul, Korea) and also serves as the CEO and Managing Director at MEDIPOST America Inc., a wholly-owned subsidiary of MEDIPOST. Since 2011, Tony has been involved in the commercialization and clinical...
Tabassum Khan / The Macro View: What will it take for Asia’s biotech industry to really flourish?
Tabassum Khan, Managing Director, A.J. Pharma Holding
Dr. Tabassum Khan is a Medical Doctor who obtained an MBA in Finance and a PhD in Healthcare Management. He is the founder and President of Stratgurus Group of Companies, headquartered at Dubai with offices in Malaysia and Europe, which conceives and manages projects in different sectors including...
Uday Saxena / The Macro View: What will it take for Asia’s biotech industry to really flourish?
Uday Saxena, Chief Scientific Officer, Dr Reddy's Laboratory
Dr. Uday Saxena is currently “Chief Mentor –in-Residence" and Professor of Translational Research at Dr. Reddy’s Institute of Life Sciences as well as Co-Founder of start-up Biotech Company. He has held Executive and Leadership positions at Parke-Davis in Ann Arbor, AtheroGenics in Atlanta...